***IF YOU HAVE PROBLEM ACESSING www.silislabs.com USE www.silislabs.co.in***


Dr. Venugopal G Somani

Dr. Rajeev Singh Raghuvanshi was appointed as the new Drug Controller General of India (DCGI), appointed on February, 2023

Dr Raghuvanshi has completed his Bachelors and Masters from IIT-BHU (Formerly IT-BHU), Varanasi and PhD from National Institute of Immunology (NII), New Delhi.

His PhD is in the area of Extended Release Formulation of Vaccines, a project to help reduce the number of injections required to be given for complete immunization. He also underwent the ISB-Kellogg Global Advanced Management Programme.

He worked for seven years at NII, he moved to join the leading Indian multinational pharmaceutical company Ranbaxy Laboratories Ltd. There he worked for development, registration and launch of NDDS, generics and branded generics in various global markets.

After having spent 12 years with Ranbaxy Laboratories, he moved to Dr Reddy's Laboratories Ltd, Hyderabad. During his 11-year tenure at Dr. Reddy's Labs, he spent the first eight years developing NDA products for the US market. In this role, he successfully led the CMC team to get six products approved in the first review cycle by the US drug regulator.

Dr Raghuvanshi's expertise lies in dosage form design and development, mainly in the domain of pharmaceutical innovation.

He has been involved in development of different kind of products like oral solids, oral liquids, topicals, injections, nasal sprays, auto-injectors, sublingual, mouth dissolve, extended release and delayed release for global markets.

More than 200 products developed by him and his teams are currently being sold in India, US Europe and Emerging Markets. Dr Raghuvanshi has 14 granted US patents along with more than 250 published PCTs and Indian Patents.

He has more than 25 publications in peer reviewed journals and has co-authored 6 chapters in books. He has been visiting faculty at NIPER - Hyderabad and IIT-BHU and has taught students of NIPER-Mohali.

He is a regular speaker at different International and National conferences on Pharmaceutical Innovation. For his contribution, Dr Reddy's Labs has twice awarded him with “Dr Reddy's Excellence Award”. Leadership development has been his passion and many of his team members mentored by him are holding leadership roles in Indian and global pharmaceutical companies.

Copyright © 2024 Silis Labs Pvt. Ltd.                                                 Developed & Maintained By iSummation Technologies